全视网膜光凝联合和血明目片治疗糖尿病视网膜病变
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Panretinal photocoagulation combined with hexuemingmu tablet for the treatment of diabetic retinopathy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察全视网膜光凝联合和血明目片治疗糖尿病视网膜病变的疗效。方法:对门诊确诊的53例100眼糖尿病视网膜病变患者,行全视网膜光凝术联合和血明目片治疗,随访3mo,对比分析其治疗前后视力、视野、眼底彩照和荧光血管造影改变。结果:视力改善65眼(65%),稳定25眼(25%),恶化10眼(10%);视野改善51眼(51%),稳定34眼(34%),恶化15眼(15%);眼底彩照和荧光血管造影提示改善80眼(80%),无变化10眼(10%),恶化10眼(10%)。结论:全视网膜光凝联合和血明目片治疗可在较短时间内稳定并改善糖尿病视网膜病变,提高视力。

    Abstract:

    AIM:To observe the effect of panretinal photocoa-gulation(PRP) combined with hexuemingmu for the treatment of diabetic retinopathy(DR). METHODS:PRP and hexuemingmu tablet were used in treating 53 cases(100 eyes) who had been diagnosed with DR.The follow-up period was 3 months. The pre-and postoperative results of visual acuity(VA),vision field (VF),fundus photograh and fundus fluoresceine angiography(FFA) were compared.RESULTS:VA was improved in 65 eyes(65%),remained unchanged in 25 eyes(25%) and decreased in 10 eyes(10%); VF was improved in 51 eyes(51%),remained unchanged in 34 eyes(34%) and decreased in 15 eyes(15%); fundus photograh and FFA was improved in 80 eyes(80%),remained unchanged in 10 eyes(10%) and decreased in 10 eyes(10%). CONCLUSION:PRP combined with hexuemingmu tablet is an effective method for DR. It can keep disease process stable and improve VA in a short period.

    参考文献
    相似文献
    引证文献
引用本文

韩月圣,王梅,焦瑞雪.全视网膜光凝联合和血明目片治疗糖尿病视网膜病变.国际眼科杂志, 2010,10(1):173-174.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
文章二维码